Probing for integrin αvß3 binding of RGD peptides using fluorescence polarization

被引:31
作者
Wang, W
Wu, Q
Pasuelo, M
McMurray, JS
Li, C
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA
关键词
D O I
10.1021/bc049763s
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Integrin alpha(v)beta(3) is an adhesion molecule involved in tumor invasion, angiogenesis, and metastasis. There is substantial interest in developing novel agents that bind to integrin alpha(v)beta(3). Here we report the synthesis and characterization of a fluorescent integrin alpha(v)beta(3) probe and its use in a nonradioactive, simple, sensitive fluorescence polarization (FP) assay to quantify binding to integrin alpha(v)beta(3) For assay validation, the FP assay was compared to a cell adhesion assay. In the two assays, probe binding to integrin alpha(v)beta(3) showed a similar dependence on probe concentration. The FP assay was successfully applied to measure the binding affinity to integrin alpha(v)beta(3) of several cyclic peptides containing the Arg-Gly-Asp (RGD) motif. The FP assay we describe here may be appropriate for high-throughput screening for integrin alpha(v)beta(3)-binding ligands used for anti-integrin therapy or noninvasive imaging of integrin expression.
引用
收藏
页码:729 / 734
页数:6
相关论文
共 25 条
[1]   Identification of a novel class of small-molecule antiangiogenic agents through the screening of combinatorial libraries which function by inhibiting the binding and localization of proteinase MMP2 to integrin αvβ3 [J].
Boger, DL ;
Goldberg, J ;
Silletti, S ;
Kessler, T ;
Cheresh, DA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (07) :1280-1288
[2]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[3]   ANTIINTEGRIN ALPHA-V-BETA-3 BLOCKS HUMAN BREAST-CANCER GROWTH AND ANGIOGENESIS IN HUMAN SKIN [J].
BROOKS, PC ;
STROMBLAD, S ;
KLEMKE, R ;
VISSCHER, D ;
SARKAR, FH ;
CHERESH, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (04) :1815-1822
[4]   Inhibition of the alpha-ν integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo [J].
Buerkle, MA ;
Pahernik, SA ;
Sutter, A ;
Jonczyk, A ;
Messmer, K ;
Dellian, M .
BRITISH JOURNAL OF CANCER, 2002, 86 (05) :788-795
[5]   MicroPET and autoradiographic imaging of breast cancer αv-integrin expression using 18F- and 64Cu-labeled RGD peptide [J].
Chen, XY ;
Park, R ;
Tohme, M ;
Shahinian, AH ;
Bading, JR ;
Conti, PS .
BIOCONJUGATE CHEMISTRY, 2004, 15 (01) :41-49
[7]   N-methylated cyclic RGD peptides as highly active and selective αvβ3 integrin antagonists [J].
Dechantsreiter, MA ;
Planker, E ;
Mathä, B ;
Lohof, E ;
Hölzemann, G ;
Jonczyk, A ;
Goodman, SL ;
Kessler, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (16) :3033-3040
[8]   The role of αv integrins during angiogenesis:: insights into potential mechanisms of action and clinical development [J].
Eliceiri, BP ;
Cheresh, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1227-1230
[9]   INVOLVEMENT OF INTEGRIN ALPHA-V GENE-EXPRESSION IN HUMAN-MELANOMA TUMORIGENICITY [J].
FELDINGHABERMANN, B ;
MUELLER, BM ;
ROMERDAHL, CA ;
CHERESH, DA .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (06) :2018-2022
[10]  
Haubner R, 2001, CANCER RES, V61, P1781